IL-6 inhibition in CKD for CV risk reduction
Educational information
This video was recorded during the virtual congress of the ACC.21.
Faculty
Dr. Paul M Ridker is the Eugene Braunwald Professor of Medicine at the Harvard Medical School and directs the Center for Cardiovascular Disease Prevention, a translational research unit at the Brigham and Women’s Hospital in Boston, MA, USA.
Disclosures
The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.
Read our summary of this trial
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: